— Indiana University
From R&D to Return on Investment: The Business of Life Sciences Research
An Undergraduate Lunch with IU
Chemistry Professor Richard DiMarchi
From research and development to return on investment: How do we ensure that advances in laboratory research-whether to address diabetes, cancer, heart disease or other threats to our health-are effectively and affordably translated into advances in pharmaceutical and medical technology, considering the corporate and regulatory environment of the industry? Join Professor Richard DiMarchi, the Standiford H. Cox Professor of Chemistry and the Linda & Jack Gill Chair in Biomolecular Sciences at Indiana University, for a discussion of the process by which innovative scientific research becomes a business and eventually is incorporated into clinical practice. As the co-founder of biopharmaceutical companies Ambrx, Inc. and Marcadia Biotech and the co-inventor of more than 90 patents, Professor DiMarchi will share his insights on the relationships between academic, biotechnology, and pharmaceutical company research, with particular attention to financial return on investment and the impact on the practice of medicine. For more on Professor DiMarchi, please visit these websites: http://dimarchi.chem.indiana.edu/; http://www.indiana.edu/~rdmweb/. The program will include time for your questions.
SIGN-UP INFO: The lunch is open to any IU undergraduate and is co-sponsored by the Hutton Honors College and the Wells Scholars Program. If you are interested in attending, please e-mail Anna Duquaine (email@example.com), indicating you wish to sign up for the "life sciences lunch" and include your name, e-mail address, year in school, and field(s) of study. Space is limited so we will let you know by e-mail if a space was available when you replied.